Achievements (Clinical & Research)

Surgeries

Procedures such as endovascular embolization, endovenous ablation, sclerotherapy, high ligation, and vein stripping are selected according to the patient’s condition, with day-case treatment as the standard.

In 2024, 412 cases (585 limbs) were treated surgically.

Performance in the Last 5 Years

Research Achievements Ethics Committee Approvals (Since 2021)

• Short-term Outcomes of VenaSeal (Endovenous Embolization) for Varicose Veins (Approved 2021/7/13, IRB2021041)

• Improvement in Symptoms Beyond Treated Limbs and Analysis of Extracellular Water Ratios After Varicose Vein Surgery (Approved 2022/1/9, IRB2022020)

• Subjective and Objective Improvement Following Foot Care Guidance for Functional Chronic Venous Insufficiency (Approved 2023/5/8, IRB2023030)

• Clinical Validation of Coronary Artery Disease Diagnosis in Chronic Venous Insufficiency Using Coronary Calcium Scores (Approved 2023/12/6, IRB2023062)

• Case Report: Postoperative Symptom Improvement Beyond Treated Limbs with Extracellular Water Ratio Analysis (Approved 2024/1/10, IRB2024007)

• Verification of Coronary Disease as an Independent Risk Factor for Chronic Venous Insufficiency Using Coronary Calcium Scores (Approved 2024/3/4, IRB2024012)

• Residual Symptoms at 6 Months Post-Surgery and the Impact of Enhanced Foot Care Guidance (Approved 2024/3/4, IRB2024013)

Conference Presentations (Since 2021)

2021

• S. Tomita et al., Short-term Results and Trends in Distance from the Saphenofemoral Junction to the Plugged End of the Great Saphenous Vein after Cyanoacrylate Closure (CC), Japanese Society of Phlebology International Session, 2021/9/7.

• Sh. Tomita et al., Morphological Changes in Occlusion Distance and Blind End after Endovenous Embolization, 41st Annual Meeting of the Japanese Society of Phlebology, 2021/9/6.

2022

• S. Tomita et al., One-Year Outcomes and Distance Trends Post-VenaSeal Closure, 42nd Annual Meeting of the Japanese Society of Phlebology, 2022/7/7-8.

2023

• S. Tomita et al., Surgery for Varicose Veins May Reduce Edema in Untreated Body Parts, AVLS and UIP World Congress, Miami.

• Sh. Tomita et al., Cases Showing Reduced Edema Beyond Treated Limbs after Varicose Vein Surgery, 43rd Annual Meeting of the Japanese Society of Phlebology.

2024

• Multiple international and domestic presentations, including the 24th European Venous Forum and 44th Annual Meeting of the Japanese Society of Phlebology.

Awards (Since 2021)

• 2023: 3rd Prize, Best Poster Presentation, AVLS & UIP World Congress, Miami, USA.

• 2024: Special Academy Award for Foot Disease Videos, 5th Annual Meeting of the Japan Foot Care and Podiatric Medicine Society.

Publications (Since 2021)

• S. Tomita et al., Changes in Morphology and Distance Post-Endovenous Embolization for Great Saphenous Vein Insufficiency, Phlebology, 2024.

• Contributions to clinical guides and international journals in vascular medicine and nursing.

Lectures (Since 2021)

Delivered at various academic, public, and professional forums, covering topics like new treatments for varicose veins, chronic venous insufficiency, and comprehensive foot care approaches.

Events

• 2nd Gifu Heart Center Foot Day, 2024/2/10.

• Short-term Outcomes of VenaSeal (Endovenous Embolization) for Varicose Veins (Approved 2021/7/13, IRB2021041)

• Improvement in Symptoms Beyond Treated Limbs and Analysis of Extracellular Water Ratios After Varicose Vein Surgery (Approved 2022/1/9, IRB2022020)

• Subjective and Objective Improvement Following Foot Care Guidance for Functional Chronic Venous Insufficiency (Approved 2023/5/8, IRB2023030)

• Clinical Validation of Coronary Artery Disease Diagnosis in Chronic Venous Insufficiency Using Coronary Calcium Scores (Approved 2023/12/6, IRB2023062)

• Case Report: Postoperative Symptom Improvement Beyond Treated Limbs with Extracellular Water Ratio Analysis (Approved 2024/1/10, IRB2024007)

• Verification of Coronary Disease as an Independent Risk Factor for Chronic Venous Insufficiency Using Coronary Calcium Scores (Approved 2024/3/4, IRB2024012)

• Residual Symptoms at 6 Months Post-Surgery and the Impact of Enhanced Foot Care Guidance (Approved 2024/3/4, IRB2024013)